Domov › Okužbe s COVID-19 in koronavirusom › Kalifornija
Klinične študije za Okužbe s COVID-19 in koronavirusom v Kalifornija
12 študij za Okužbe s COVID-19 in koronavirusom išče udeležence na lokacijah v Kalifornija.
Mesta v Kalifornija
Uradno besedilo študije (angleško)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Fresno
- Research Site, Newport Beach
- Research Site, Torrance
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Hope Clinical Research, Inc., Canoga Park
- Amicis Research Center - Granada Hills, Granada Hills
- Jacobs Medical Center at UC San Diego Health, La Jolla
- in še 4
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of California, Los Angeles (UCLA), Los Angeles
- University of California San Francisco, San Francisco
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- National Institute of Clinical Research - Bakersfield, Bakersfield
- Velocity Clinical Research, Huntington Park, Huntington Park
- 310 Clinical Research, Inglewood
- in še 9
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06679140Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 0–20 · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT04278404A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
- UCLA Westwood, Los Angeles
- UCSF Community and Clinical Research Center, San Francisco
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 40–64 · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci
Starost 18–64 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT07730450Long-term Impact of Infection With Novel Coronavirus (COVID-19)
- Zuckerberg San Francisco General Hospital (ZSFG), San Francisco
Vključevanje udeležencevOpazovalna študija
Starost 18–100 · Vsi spoli · Posodobljeno 23. jul. 2026 · NCT04362150Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- City of Hope cancer Center, Duarte
- University of California Davis Health System, Sacramento
Vključevanje udeležencevFaza 3
Vse starosti · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT03808922Impact of the Coronavirus (COVID-19) on Patients With Cancer
- Stanford University School of Medicine, Stanford
Vključevanje udeležencevOpazovalna študija
Starost 18–99 · Vsi spoli · Posodobljeno 27. apr. 2026 · NCT04330521Understanding Immunity to the Flu Vaccine in COVID-19 Patients
- Stanford University, Palo Alto
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 9–64 · Vsi spoli · Posodobljeno 18. mar. 2026 · NCT04579588Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
- Department of Emergency Medicine, Children's Hospital of Los Angeles, Los Angeles
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–60 · Vsi spoli · Posodobljeno 5. sep. 2025 · NCT05868239Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.